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The MCD peptide in bee venom induces degranulation in mast cells. The internal calcium concentration of mast cells increased and remained 
high following MCD stimulation. This calcium increase was blocked by pertussis toxin (Ptx) treatment. suggesting that MCD peptide activates 
Ptx-sensitive G-protein. Even in the absence of external calcium in the incubation medium, the calcium concentration increased by MCD treatment. 
but soon returned to the original level. D-MCD, the optical isomer of the MCD peptide, also increased the internal calcium concentration through 
a Ptx-sensitive pathway. We suggest that cationic clusters at one side of the surface are more important in activating the G-protein than the r-helix 
conformation. 
Mast cell de~ranulattng peptide: Mast cell: G-protein: a-Helix; Optical isomer 
I. INTRODUCTION 
Histamine release by rat peritoneal mast cells has 
been extensively used as a model of exocytosis [ 11. The 
introduction of non-hydrolyzable analogs of GTP that 
persistently activate CTP-binding proteins into mast 
cells induces exocytosis 121. This suggests that G- 
proteins play a role in the cascade of events leading to 
histamine secretion [1,2]. The early events after 
stimulation of mast cells include the breakdown of 
phosphoinositides (PIPl), a rise in the internal Ca”+ 
concentration and the generation of arachidonic acid 
[l--3]. However, these signaling pathways and their 
relative role in secretion remain to be clarified. 
A wasp venom, mastoparan, is known to induce 
histamine release from mast cells [4,5]. It has previously 
been shown that mastoparan activates G-proteins and 
stimulates their GTPase activity, leading to histamine 
release 161. When mastoparan is bound to a 
phospholipid bilayer, it forms an B-helix that lies 
parallel to the plane of the membrane, with its 
hydrophobic face within the bitayer and its four 
positive charges facing outward; thus, this peptide has 
an amphiphilic property [7,8]. This conformation is 
thought to mimic the structure of the interaction site of 
agonist-liganded receptors with the G-protein [9,10]. 
Disruption of the a-helix conformation and the am- 
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phiphilic property by replacing the amino acid residues 
of mastoparan results in the loss of the ability to ac- 
tivate the G-protein [ll]. However, it is not clear which 
is more important for the activation of the G-protein, 
a-helix formation or cationic clusters at one side of the 
surface. 
We have been studying the molecular mechanism that 
underlies the ~nductio~l of long-term potentiation (LTP) 
of synaptic transmission efficacy induced by the mast- 
cell-degranulating (MCD) peptide in bee venom [ 12, i 31. 
This MCD peptide is a highly basic toxin of 22 amino 
acids with two disulfide bonds [14]. It also causes mast 
cells to release histamine, as does mastoparan [15,16]. 
The structure of the MCD peptide has been elucidated 
through NMR studies: it was shown to contain an N- 
helix structure with an amphiphilic property, fixed by 
two disulfide bonds at its C-terminal [17]. Thus, it was 
intriguing to investigate whether histamine release caus- 
ed by the MCD peptide also involves the activation of 
G-protein. G-protein acti~~ation has been shown to play 
an important role in long-term potentiation (LTP) for- 
mation in the hippocampus [18,19], and therefore, it 
would also aid in understanding the mechanism 
underlying MCD-induced LTP if this were the case. In 
this paper, we show that the MCD peptide causes an in- 
crease in the intracellular calcium level of mast cells via 
a G-protein-dependent pathway. Moreover, the com- 
plete optical isomer of MCD, which was synthesized by 
replacing all amino acid residues of the MCD peptide 
with D-amino acids, also activates the G-protein in 
mast cells. This indicates that cationic clusters at one 
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side of the molecular surface are more important than 
the D-helical conformation of the backbone in ac- 
tivating the G-protein in mast cells. 
2. MATERIALS AND METHODS 
Peptide-chain elongation wan carried OLII on an Applied Biosystem 
peptide synthesircr Model 43OA. Two S-S bonds \+ere selectiveI> 
formed by air oxidation and iodide ouldation. The) \%erc purified by 
SP-Sephadex C-25 column chromatography (2.8 x 30 cm Pharmacia, 
Uppsala, S\+eden), re\er,ed-phase HP1.C (1.9 x 15.0 cm ItHonda- 
sphere 5~ C8-300A, U’ater,, Tokyo, Japan) and ion-cxchanpe HPLC 
(0.75 x 7.5 cm TSK SP-SPN’, Towh. ?oL!o. Japan) a\ dc\cl-ibed in 
detail [13]. 
Mact cells were obtained from the peritoneal cavity of M’ictar rats 
and purified through metriramide gradient centrifugation as de- 
vxibcd 1201. Mast cells were collected from the pellet at a purity of 
>900’0. The cell5 were incubated for 2 h at 37-c‘ with pertu$Gr toxin 
at IO ng:ml or 100 ng/ml in KIngel- solution a$ dext-ibed pre\iou\l) 
[I .20]. Control cell\ \\ere incubated \\ithout PI\ fol the tame period. 
Ptx-treated and control cell\ were incubated \\ith 1 PM Fura2,Ahl 
(Dojindo, Japan) in Ringer solution at 37°C‘ for 15 min, resuspended 
in I .5 ml of fresh Ringer wlution at 0.3 x IO’ cell\/ml in a {tarring 
cucette and measured by k-2000 fluoretcence ~pectrophotomctel 
(Hitachi, Japan). Eml,,ion \%a5 monitored at 510 nm after excitation 
with I\\O different xbnvelengthi (340 nm and 380 nm): lilci, Flxi,. The 
\witching time for the t\\o wavelength\ ~a\ 0.5 5. The concentration 
of CaL was calculated by the follo\Qing equation\: R,,,,,, = 
I ~_,,,,,,, 1401 ~-zi I /‘I ~-n,,,,cMo, ~ zz I , R,,,.,, r I ~;,,.,,,ullr ~ Zl I ’ I ~;,,,,x,wl, - 
z21. K = ~~11,,-~,I~ll;ixo-z~I. [(‘a2’J = 223 nX1 (CR R,,,,,,),, 
(Km.,, - R) I I F-,ri,,i,~r~~~~~-,;lnr,(lx~~, 1 
Z, and ZZ are the autofluorcscence inten\itic\ at 340 nm and 
380 nm before Fura \\a5 loaded. k ,,,,,,~~x,~, is the fluol-ewence inten\it> 
for flee dye at 380 nm and F ,,,,lr~~~li, i\ that for C‘a’--bound d>c at 
380 nm. I-,,,,,,,Iw, and I.. ,,l.iz(~~~~, arc the fluorewence inten\ltic\ for free 
dye and Ca’+-bound dye at 340 nm. 
0 100 200 300 set 
Fig. I Into-acellular calcium conccntt-atio11 in majt cell\ stimulated 
\\ith YIC‘D. \lCD (I ,ij\l) \+a\ added to 3-5 x 10‘ ccII\ml of mast 
cells loaded with kura2 at the point indicated b! iwo\! \. .Thc calcium 
concentration ~a\ measured a’ dexrlbed 111 xctior 2. A, control; B 
and C, the cells \\ere prelncubated for 2 h a~ 37 c‘ \\ith IO ngjml and 
100 ng/ml, re\pecti\el!, of pcrtussib totin: 0, calcium \la\ rcmo\ed 
3. RESULTS AND DISCUSSION from the incubation medium 17) adding L.C;TA. 
MCD peptide has been characterized by its potent 
ability to induce degranulation in mast cells [ 15,161. 
When mast cells loaded with Fura were stimulated 
with MCD peptide (1 PM), the internal calcium concen- 
tration increased and reached the maximum level soon 
after stimulation (Fig. IA). The calcium level declined 
slowly thereafter, reaching a constant level substantially 
higher than the original level. G-protein is known to 
play a crucial role in the degranulation process induced 
by various chemoattractants, e.g. mastoparan and 
Compound 481’80 [I ,7,20]. 
To examine the possible involvement of G-protein in 
this process, the internal calcium concentration was 
analyred in mast cells that were pretreated with 
10 ng/ml or 100 ng/ml pertussis toxin (Ptx) for 2 h 
(Fig. lB,C). The increase in the calcium level after 
stimulation with 1 PM MCD peptide was suppressed in 
a dose-dependent manner. Therefore, inactivation of 
G-protein(s) sensitive to Ptx treatment reduced the 
response of mast cells to\vard MCD peptide treatment. 
We then investigated the source of the calcium. When 
external calcium was removed from the incubation 
medium 1 min before hlCD peptide treatment by ad- 
ding EGTA (2 m.M), the initial rise in calcium concen- 
tration still occurred, ho\vever, it soon returned to the 
original level (Fig. ID). These results indicate that the 
MCD peptide increases the intracellular calcium con- 
centration by activating the G-protein and that the in- 
itial transient increase in calcium concentration is in- 
dependent of external calcium, Lvhile the latter sus- 
tained increase is dependent. The initial small peak 
might be induced through an inositol 1,4,5-trisphos- 
phate (IPi)-dependent pathway [ 1,3,2 1,221. These ef- 
fects of the MCD peptide tolvard mast cells resemble 
those of mastoparan. 
The relationship between structure and function has 
been well studied in mastoparan, and it has been shown 
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Fig. 2. intracellular calcium concentration in mast cells stimulated 
with D-MCD, the optical isomer of MCD. D-MCD (1 PM) was added 
to 3-5 x lo” cells/ml of mast cells loaded with Fura at the point 
indicated by arrows. The calcium concentration was measured as 
described in section 2. A, control; B and C, the cells were 
preincubated for 2 h at 37°C with 10 ng/ml and 100 ng/ml, 
respectively, of pertussis toxin. 
that disrupting the a-helix conformation by replacing 
amino acid residues results in the loss of the ability to 
activate the G-protein [Ill. When the a-helix confor- 
mation with its amphiphilic property is disrupted, 
however, cationic clusters at one side of the surface will 
also be disrupted [ 111. We have shown that the MCD 
peptide has an u-helical structure at its C-terminal, 
which is fixed by two disulfide bridges, and that it also 
displays an amphiphilic property [17]. We have also 
synthesized a complete optical isomer of the MCD pep- 
tide by replacing all the amino acid residues with their 
D-isomers (D-MCD). Protein-protein (peptide) 
recognition would no longer exist if the a-helical con- 
formation were changed to its optical isomeric form, 
while the ionic clusters on the surface of the two optical 
isomers should be the same. Therefore, this peptide 
provides a unique opportunity to investigate which pro- 
perty of the peptide is essential for G-protein activa- 
tion, the a-helical conformation or cationic clusters at 
one side of the molecule. The D-MCD-induced increase 
in the internal calcium level, and the time course of the 
(nM) 
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Fig. 3. Dose-response of MCD- and D-MCD-induced increases in the 
into-acellular calcium concentration. The calcium concentration was 
measured at 24°C in assay medium that contained 2 mM calcium. 
Each point represents the average of the maximum calcium increase 
aftmer 0.3 ELM or I PM of MCD or D-MCD stimulation of more than 
3 independent experiments. 
response was quite similar to that induced by the MCD 
peptide (Fig. 2A). This process was also inhibited by 
Ptx treatment (Fig. 2B,C). Fig. 3 shows the maximum 
increase in calcium levels after treatment with the 
designated concentrations of MCD or D-MCD peptide. 
D-MCD peptide activated the G-protein almost to the 
same extent as the MCD peptide, although it was slight- 
ly less effective at a lower concentration (0.3 ,uM). 
These results suggested that cationic clusters at one side 
of the surface were more important in activating the G- 
protein than the a-helix conformation. 
Since the G-protein(s) is (are) known to play an im- 
portant role in LTP induction, it is necessary to study 
the interaction of the MCD peptide with the G-protein 
in brain. 
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